Log in

Log error View Profile Edit Profile Manage Subscriptions My Saved Content Logout

Industries
Capabilities
BCG X
Featured Insights
- Featured Insights
- Explore Our Featured Insights
- Artificial Intelligence
- Climate Change and Sustainability
- BCG Executive Perspectives
- Business Resilience
- Build for the Future
- Podcasts by BCG
- Future of Work
- TED@BCG
BCG Henderson Institute
Careers
Alumni
About
- About
- About Overview
- Our People and Culture
- Corporate Newsroom
- Our Leadership
- Our Commitments
- Our History
Offices

Featured Content

BCG’s New Tech Build and Design Unit

BCG X disrupts the present and creates the future by building bold new tech products, services, and businesses.
Business Resilience

Leaders face an uncertain landscape. No matter their starting point, BCG can help.
Build for the Future

BCG’s research reveals six key success factors and the steps companies need to take today.

Contact Us

© 2023 Boston Consulting Group
Privacy
Terms of Use
Subscribe

Site Search

View our biopharma services

The Changing Role of Medical Affairs in Biopharma

Myrto Lee, a managing director and partner at BCG, talked with Sunil Verma, head of medical oncology at AstraZeneca, and Michael Norton, a BCG senior advisor, about how biopharma companies can use the medical affairs function to improve health outcomes for a more diverse set of patients.

Share

Meet the Speakers

Managing Director & Partner

London

Michael Norton | square

Michael Norton

Senior Advisor

Denver

Explore Related Services

Health Care Industry

Biopharma

Health Care Payers, Providers, Systems & Services

Follow Us

Global | EN

© 2023 Boston Consulting Group
Careers
Contact
Subscribe
Alumni
About
Offices
Privacy Policy
Terms of Use
Sitemap
Responsible Disclosure

Boston Consulting Group is an Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, age, religion, sex, sexual orientation, gender identity / expression, national origin, protected veteran status, or any other characteristic protected under federal, state or local law, where applicable, and those with criminal histories will be considered in a manner consistent with applicable state and local laws.

Pursuant to Transparency in Coverage final rules (85 FR 72158) set forth in the United States by The Departments of the Treasury, Labor, and Health and Human Services click here to access required Machine Readable Files or here to access the Federal No Surprises Bill Act Disclosure.

The Changing Role of Medical Affairs in Biopharma

SUBSCRIBE

Log in

Log error View Profile Edit Profile Manage Subscriptions My Saved Content Logout